Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary vasculitis.

Kevin K Brown1

  • 1Pulmonary Division, Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA. brownk@njc.org

Proceedings of the American Thoracic Society
|February 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continued Nintedanib Treatment in Children and Adolescents With Fibrosing ILDs: Data From InPedILD-ON.

Pediatric pulmonology·2026
Same author

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials.

ERJ open research·2026
Same author

Switch-like methylation of functional pathways distinguishes COPD and idiopathic pulmonary fibrosis.

medRxiv : the preprint server for health sciences·2025
Same author

One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease.

American journal of respiratory and critical care medicine·2025

Pulmonary vasculitis involves blood vessel destruction in the lungs. This article focuses on antineutrophil cytoplasmic antibody-associated vasculitides, common causes of lung inflammation.

Area of Science:

  • Pulmonary Medicine
  • Rheumatology
  • Pathology

Background:

  • Pulmonary vasculitis encompasses diverse disorders characterized by blood vessel destruction.
  • Clinical presentation varies based on vessel size, type, and location.
  • Diagnosis requires integrating clinical, radiologic, laboratory, and pathologic findings.

Purpose of the Study:

  • To review pulmonary vasculitis, emphasizing common antineutrophil cytoplasmic antibody-associated conditions.
  • To highlight the diagnostic approach for lung involvement in vasculitic disorders.

Main Methods:

  • Review of literature on pulmonary vasculitis.
  • Focus on antineutrophil cytoplasmic antibody-associated vasculitides (ANCA-associated vasculitides).

Related Experiment Videos

Main Results:

  • Lung involvement is frequent in small-vessel ANCA-associated vasculitides like Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome.
  • Medium and large-vessel vasculitis, immune complex-mediated vasculitis, and secondary vasculitis can also affect the lungs.

Conclusions:

  • Pulmonary vasculitis presents a diagnostic challenge requiring comprehensive evaluation.
  • ANCA-associated vasculitides are a primary focus due to their common presentation with lung disease.